Across the developmental continuum of irritable bowel syndrome: Clinical and pathophysiologic considerations

Current Gastroenterology Reports

Volumn 6, Issue 3, 2004, Pages 247-253

  Besedovsky, Andres ^b   Li, B U K ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALOSETRON; AMITRIPTYLINE; BISACODYL; CHOLECYSTOKININ; CIMETROPIUM; DESIPRAMINE; FAMOTIDINE; FRUCTOSE; HYOSCYAMINE; IMIPRAMINE; LAXATIVE; LOPERAMIDE; MACROGOL; MAGNESIUM; NORTRIMIPRAMINE; PEPPERMINT OIL; PLACEBO; PROKINETIC AGENT; SENNA EXTRACT; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SIMETHICONE; SORBITOL; SPASMOLYTIC AGENT; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMEBUTINE; TRIMIPRAMINE; UNINDEXED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; AGE; BEHAVIOR THERAPY; BRAIN MAPPING; CHILDHOOD; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; CONSENSUS; DEFECATION; DIARRHEA; DIETARY FIBER; DIGESTIVE SYSTEM FUNCTION DISORDER; HUMAN; INFANT; INFANT DISEASE; IRRITABILITY; IRRITABLE COLON; NEUROIMAGING; PATHOPHYSIOLOGY; RECURRENT DISEASE; REVIEW; SEROTONINERGIC SYSTEM; SIDE EFFECT; STRESS; SYMPTOMATOLOGY; ADULT; CHILD; GASTROINTESTINAL MOTILITY; INFANTILE DIARRHEA; RISK FACTOR;

ABDOMINAL PAIN; ADULT; CHILD; DIARRHEA, INFANTILE; GASTROINTESTINAL MOTILITY; HUMANS; INFANT; IRRITABLE BOWEL SYNDROME; RISK FACTORS;

EID: 4544378724     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-004-0015-4     Document Type: Review

References (61)

1. Sandler RS: Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990, 99: 409-15.
2. Manning AP, Thompson WG, Heaton KW, Morris AF: Towards a positive diagnosis of irritable bowel. BMJ 1978, 38: 1569-1580.
3. Thompson WG, Dotevall G, Drossman DA, et al.: Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989, 2: 92-95.
4. Thompson WG, Longstreth GF, Drossman DA, et al.: Functional bowel disorders and functional abdominal pain. Gut 1999, 45: II43-II46.
5. Longstreth GF, Wolde-Tsadik G: Irritable bowel-type symptoms in HMO examiners: prevalence, demographics and clinical correlates. Dig Dis Sci 1993, 38: 1581-1589.
6. Drossman DA, Sandler RS, McKee DC, Lovitz AJ: Bowel patterns among subjects not seeking health care: use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 1982, 83: 529-534.
7. Hyams IS, Burke G, Davis PM, et al.: Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. J Pediatr 1996, 129: 220-226.
8. Reijneveld SA, Brugman E, Hirasing RA: Excessive infant crying: the impact of varying definitions. Pediatrics 2001, 108: 893-897.
9. Barr RG: Infant colic. In Pediatric Functional Gastrointestinal Disorders. Edited by Hyman PE. New York: Academy Professional Information Services; 1999:2.1-2.24.
10. Wessel MA, Cobb JC, Jackson EB, et al.: Paroxysmal fussing in infancy, sometimes called 'colic'. Pediatrics 1954, 14: 421-434.
11. Lothe L, Lindberg T, Jakobsson I: Macromolecular absorption in infants with infantile colic. Acta Paediatr Scand 1990, 79: 417-421.
12. Clyne PS, Kulczycki A: Human breast milk contains bovine IgG: relationship to infant colic? Pediatrics 1991, 87: 439-444.
13. Lothe L, Ivarsson S, Lindberg T: Motilin, vasoactive intestinal peptide and gastrin in infatile colic. Acta Pediatrica Scandinavica 1987, 76: 316-320.
14. Huhtala V, Lehtonen L, Uvnas-Moberg K, Korvenranta H: Low plasma cholecystokinin levels in colicky infants. J Pediatr Gastroenterol Nutr 2003, 37: 42-46.
15. Weissbluth L, Weissbluth M: Infant colic: the effect of serotonin and melatonin circadian rhythms on the intestinal smooth muscle. Med Hypotheses 1992, 39: 164-167.
16. Sondergaard C, Henriksen TB, Obel C, Wisborg K: Smoking during pregnancy and infantile colic. Pediatrics 2001, 108: 342-346.
17. Sondergaard C, Olsen J, Friis-Hasche E, et al.: Psychosocial distress during pregnancy and the risk of infantile colic: a follow up study. Acta Paediatr 2003, 92: 811-816.
18. Hill DJ, Hudson IL, Sheffield LJ, et al.: A low allergen diet is a significant intervention in infantile colic: results of a community-based study. J Allergy Clin Immunol, 1995, 96: 886-892.
19. Lucassen PL, Asswendelft WJ, Gubbels JW, et al.: Effectiveness of treatment for infantile colic: systematic review. BMJ 1998, 316: 1503-1509.
20. Illingngworth RS: Evening colic in infants: a double-blind trial of dicyclomine hydrochloride. Lancet 1959, 2: 1119-1120.
21. Weissbluth M, Christoffel KK, Davis T: Treatment of infantile colic with dicyclomine hydrochloride. J Pediatr 1984, 104: 951-955.
22. Metcalf TJ, Irons TG, Sher ED, Young PC: Simethicone in the treatment on infantile colic: a randomized, placebo-controlled, multicenter trial. Pediatrics 1994, 94: 29-34.
23. Kneepkens F, Hoekstra H: Chronic nonspecific diarrhea of childhood. Pediatr Clin North Am 1996, 43: 375-388.
24. Milla P: Toddler Diarrhea. In Pediatric Functional Gastrointestinal Disorders. Edited by Hyman P. New York: Academy Professional Information Services; 1999:9.1-9.14.
25. Davidson M, Bauer CH: The value of microscopic examination of the stool for extracellular starch in the diagnosis of starch intolerance. Pediatrics 1958, 21: 565-571.
26. Hyams JS: Chronic abdominal pain caused by sorbitol malabsorption. J Pediatr 1982, 100: 772-773.
27. Tripp JH, Muller DPR, Harries JT: Mucosal (Na± K±)-ATPase and adenylate cyclase activities in children with toddler diarrhoea and postenteritis syndrome. Pediatr Res 1980, 14: 1382-1386.
28. Fenton TR, Harries JT, Milla PJ: Disordered small intestinal motility: a rational basis for toddlers' diarrhea. Gut 1983, 24: 897-903.
29. Cohen SA, Hendricks KM, Mathis RK, et al.: Chronic nonspecific diarrhea: dietary relationships. Pediatrics 1979, 64: 402-407.
30. Hamdi I, Dodge JA: Toddler diarrhoea: observations on the effects of aspirin and loperamide. J Pediatr Gastroenterol Nutr 1985, 4: 362-365.
31. Apley J, Naish N: Recurrent abdominal pains: a field survey of 1000 school children. Arch Dis Child 1958, 33: 165-170.
32. Rasquin-Weber A, Hyman PE, Cucchiara S, et al.: Childhood functional gastrointestinal disorders. Gut 1999, 45(Suppl 2): II60-II68.
33. Hyams J, Treem W, Justinich C, Davis P, et al.: Characterization of symptoms in children with recurrent abdominal pain: resemblance to irritable bowel syndrome. J Pediatr Gastroenterol Nutr 1995, 20: 209-214.
34. Ball TM, Weydert JA: Methodological challenges to treatment trials for recurrent abdominal pain in children. Arch Pediatr Adolesc Med 2003, 157: 1121-1127.
35. Dorn LD, Campo JC, Thato S, et al.: Psychological comorbidity and stress reactivity in children and adolescents with recurrent abdominal pain and anxiety disorders. J Am Acad Child Adolesc Psychiatry 2003, 42: 66-75.
36. Garber J, Zeman J, Walker LS: Recurrent abdominal pain in children: psychiatric diagnoses and parental psychopathology. J Am Acad Child Adolesc Psychiatry 1990, 29: 648-656.
37. Egger HL, Costello EJ, Erkanli A, Angold A: Somatic complaints and psychopathology in children and adolescents: stomach aches, musculoskeletal pains, and headaches. J Am Acad Child Adolesc Psychiatry 1999, 38: 852-860.
38. Kellow JE, Eckersley GM, Jones MP: Enhanced perception of physiological intestinal motility in irritable bowel syndrome. Gastroenterology 1991, 101: 1621-1627.
39. Humphreys PA, Gevirtz RN: Treatment of recurrent abdominal pain: component analysis of four treatment protocols. J Pediatr Gastroenterol Nutr 2000, 31: 47-51.
40. Hyams J: Chronic and recurrent abdominal pain. In Pediatric Functional Gastrointestinal Disorders. Edited by Hyman P. New York: Academy Professional Information Services; 1999:7.1-7.22.
41. Mertz H: Altered CNS processing of visceral pain in IBS. In Irritable Bowel Syndrome. Edited by Camillieri M, Spiller R. Philadephia: Elsevier Science; 2002:55-68.
42. Mertz H, Morgan V, Tanner G, et al.: Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000, 118: 842-848.
43. Silverman D, Munakata J, Eness H: Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997, 112: 62-72.
44. Gershon M: Importance of mechanisms in gastrointestinal motility and sensation. In Irritable Bowel Syndrome. Edited by Camillieri M, Spiller R. Philadelphia: Elsevier Science; 2002:95-115.
45. Portincasa P, Moschetta A, Baldassarre G, et al.: Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol 2003, 9: 2293-2299.
46. Bardhan K, Bodemar G, Geldof H, et al.: A double-blind placebo controlled study to evaluate the efficacy of alosetrom in the treatment of irritable bowel syndrome [abstract]. Gastroenterology 1996, 110: A630.
47. Shaw G, Srivastava ED, Sadlier M, et al.: Stress management for irritable bowel syndrome: a controlled trial. Digestion 1991, 50: 36-42.
48. Drossman DA: Irritable bowel syndrome and sexual/physical abuse history. Eur J Gastroenterol Hepatol 1997, 9: 327-330.
49. Salmon P, Skaife K, Rhodes J: Abuse, dissociation, and somatization in irritable bowel syndrome: towards an explanatory model. J Behav Med 2003, 26: 1-18.
50. Jamieson DJ, Steege JF: The association of sexual abuse with pelvic pain complaints in a primary care population. Am J Obstet Gynecol 1997, 177: 1408-1412.
51. Coutinho SV, Plotsky PM, Sablad M, et al.: Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gastrointest Liver Physiol 2002, 282: G307-G316.
52. Spiller R: Postinfectious irritable bowel syndrome. Gastroenterology 2003, 124: 1662-16171.
53. Kopel F, Barbero G: Comparisson in rectosigmiod motility in normal children, children with recurrent abdominal pain and children with ulcerative colitis. Pediatrics 1967, 39: 539-544.
54. Di Lorenzo C, Youssef NN, Sigurdsson L, et al.: Visceral hyperalgesia in children with functional abdominal pain. J Pediatr 2001, 139: 838-843.
55. Hyams JS, Hyman PE, Rasquin-Weber A: Childhood recurrent abdominal pain and subsequent adult irritable bowel syndrome. J Dev Behav Pediatr 1999, 20: 318-319.
56. Camilleri M, Mayer EA, Drossman DA, et al.: Improvement of pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther 1999, 13: 1149-1159.
57. Talley NJ, Owen BK, Boyce P, Paterson K: Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol 1996, 91: 277-283.
58. Drossman DA, Toner BB, Whitehead WE, et al.: Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003, 125: 19-31.
59. Jailwala J, Imperiale TF, Kroenke K: Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000, 133: 136-147.
60. Novick J, Miner P, Krause R, et al.: A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002, 16: 1877-1888.
61. Reed W, Evans B, Rhodes I: Treating the irritable bowel syndrome with peppermint oil. BMJ 1979, 2: 835-836.